Bluebird Bio Correlations
BLUE Stock | USD 8.35 0.09 1.09% |
The current 90-days correlation between Bluebird bio and Mersana Therapeutics is -0.03 (i.e., Good diversification). The correlation of Bluebird Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Bluebird Bio Correlation With Market
Good diversification
The correlation between Bluebird bio and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bluebird bio and DJI in the same portfolio, assuming nothing else is changed.
Bluebird |
Moving against Bluebird Stock
0.46 | VCEL | Vericel Corp Ord | PairCorr |
0.5 | VTRS | Viatris | PairCorr |
0.37 | DVAX | Dynavax Technologies | PairCorr |
0.32 | KTTAW | Pasithea Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bluebird Stock performing well and Bluebird Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bluebird Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MRSN | 5.51 | (1.43) | 0.00 | (0.63) | 0.00 | 9.05 | 64.16 | |||
ZNTL | 4.45 | (0.26) | 0.00 | (0.30) | 0.00 | 8.36 | 37.75 | |||
YMAB | 2.70 | (1.24) | 0.00 | (2.55) | 0.00 | 3.07 | 20.65 | |||
TVTX | 2.15 | 0.10 | 0.04 | 0.14 | 2.41 | 4.84 | 20.58 | |||
MDGL | 2.90 | 0.56 | 0.16 | 0.80 | 3.01 | 5.53 | 33.61 | |||
VKTX | 3.33 | (0.95) | 0.00 | (1.11) | 0.00 | 4.89 | 39.28 | |||
SRPT | 1.84 | (0.06) | 0.00 | (0.14) | 0.00 | 3.38 | 18.92 | |||
HEPA | 4.89 | (0.08) | 0.00 | (0.22) | 0.00 | 9.33 | 41.03 | |||
PTCT | 2.60 | 0.22 | 0.08 | 0.90 | 2.58 | 6.61 | 23.75 | |||
AGIO | 3.06 | (0.28) | 0.00 | (0.33) | 0.00 | 6.76 | 31.56 |
Bluebird Bio Corporate Management
Mr MD | Chief Officer | Profile | |
Melissa Bonner | VP Research | Profile | |
Andrea Walton | Chief Officer | Profile | |
JD Esq | Chief Secretary | Profile | |
Christopher CPA | Principal CFO | Profile |